Sovereignty is measured in milligrams.
Who makes the medicine, who holds the data, who sets the rules. These look like technical questions. They decide how much sovereignty a country actually has.
Speaking
Health security has moved out of health ministries. It is now decided in trade policy, industrial strategy and foreign affairs — and most organisations are still discussing it as a procurement problem.
I speak to boards, ministries and international convenings about what that shift means in practice, and where the room for manoeuvre still is.
- KeynoteThe molecule and the map
- KeynoteWho owns the genome of a nation
- PanelEurope, the Gulf and the speed of institutions
- BriefingHealth sovereignty for boards
The Health Order
In March 2020 a single notification from the Indian Directorate General of Foreign Trade restricted the export of paracetamol, and Europe discovered it had no way to make its own.
We called it a supply chain problem. It was a sovereignty problem, and it had been building for thirty years.
The Health Innovation Corridor
Europe does not lose because its science is weak. It loses because its science leaves.
On building shared institutional capacity between Europe and the Gulf - from qualification framework to first customer.
9 sectors · a 24-month pilot · Europe-Gulf